Authors: | Elkrief, A.; Yu, H. |
Title: | Combination regimens in EGFR-mutated lung cancer: Can we get ORIENT-ed? |
Keywords: | cancer survival; gene mutation; overall survival; genetics; mutation; bevacizumab; cisplatin; drug efficacy; note; gene; progression free survival; protein kinase inhibitor; carcinoma, non-small-cell lung; lung neoplasms; epidermal growth factor receptor; lung cancer; protein kinase inhibitors; lung tumor; lung metastasis; platinum derivative; egfr gene; pemetrexed; egfr protein, human; non small cell lung cancer; erbb receptors; humans; human; osimertinib; atezolizumab; sintilimab |
Journal Title: | Lancet Oncology |
Volume: | 23 |
Issue: | 9 |
ISSN: | 1470-2045 |
Publisher: | Elsevier Science, Inc. |
Date Published: | 2022-09-01 |
Start Page: | 1113 |
End Page: | 1114 |
Language: | English |
DOI: | 10.1016/s1470-2045(22)00449-1 |
PUBMED: | 35908559 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Note -- Export Date: 3 October 2022 -- Source: Scopus |